On January 12, Sir Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine successfully carried out the first Co-Ablation System’s ablation of solid tumor in Zhejiang, which was a complete success.

It is reported that the patient was clinically diagnosed with intrahepatic cell carcinoma. Two years after surgical resection of the left hepatic lobe, multiple metastatic lesions in the right hepatic lobe were detected. After evaluation by the expert team, the Co-Ablation by the Co-Ablaiton System under the guidance of ultrasound can be implemented.After preoperative communication, it was decided to perform the operation, and it was finally successful.

On the same day, Hygea Medical and Sr Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine jointly held the Co-Ablation System treatment of solid tumor startup meeting in 2022. Cai Xiujun, President of Sr Run Run Shaw Hospital Affiliated to Zhejiang University, Liang Xiao, Professor of Zhejiang University, and Feng Huasong, Professor of the Sixth Medical Center of  PLA General Hospital, Huang Wenming, Deputy General Manager of Hygea Medical, Ding Bo, Director of Sales Department of Hygea Medical, Huang Xinfu, Sales Manager of East China Region of Hygea Medical, and directors of various departments of Sr Run Run Shaw Hospital attended the meeting.

The two parties of the launch conference discussed the extensive application of Co-Ablation System in different departments, and exchanged important opinions and views. President Cai Xiujun gave high recognition and evaluation.

Hygea Medical has developed a Co-Ablation tumor minimally invasive device Co-Ablation System, which integrates ultra low temperature cryoablation and high temperature hyperthermia ablation. The company has been committed to providing a series of medical solutions on effective tumor interventional therapy.